Cargando…
552. Effect of Lactococcus lactis strain plasma (LC- Plasma) on immune response and symptoms in patients with mild COVID-19. Result of the multicenter, double- blinded, randomized controlled trial (PLATEAU study)
BACKGROUND: The COVID-19 epidemic has been repeated worldwide; however, easily accessible treatment options for patients with mild COVID-19 remain limited. Since the Lactococcus lactis strain plasma (LC- Plasma) enhances both the innate and acquired immune systems through the activation of plasmacyt...
Autores principales: | Yamamoto, Kazuko, Inoue, Tsuyoshi, Jounai, Kenta, Tsuji, Ryohei, Fujiwara, Daisuke, Iwanaga, Naoki, Ikeda, Takaya, Sawai, Toyomitsu, Nagayoshi, Yosuke, Hashiguchi, Koji, Futsuki, Yohji, Matsubara, Yuichi, Hosogaya, Naoki, Yanagihara, Katsunori, Izumikawa, Koichi, Mukae, Hiroshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677221/ http://dx.doi.org/10.1093/ofid/ofad500.621 |
Ejemplares similares
-
Efficacy of Lactococcus lactis strain plasma (LC-Plasma) in easing symptoms in patients with mild COVID-19: protocol for an exploratory, multicentre, double-blinded, randomised controlled trial (PLATEAU study)
por: Yamamoto, Kazuko, et al.
Publicado: (2022) -
Efficacy of clarithromycin in patients with mild COVID-19 pneumonia not receiving oxygen administration: protocol for an exploratory, multicentre, open-label, randomised controlled trial (CAME COVID-19 study)
por: Yamamoto, Kazuko, et al.
Publicado: (2021) -
Plasmacytoid dendritic cells stimulated with Lactococcus lactis strain Plasma produce soluble factors to suppress SARS-CoV-2 replication
por: Ishii, Hiroshi, et al.
Publicado: (2023) -
Lactococcus lactis Strain Plasma Improves Subjective Physical State and Presenteeism: A Randomized, Open-Label Crossover Study among Healthy Office Workers
por: Kokubo, Takeshi, et al.
Publicado: (2020) -
Relapsed Pulmonary Cryptococcosis during Tumor Necrosis Factor α Inhibitor Treatment
por: Takazono, Takahiro, et al.
Publicado: (2016)